Take the free GLP-1 qualification quiz at [https://go.telehealthfx.com/start](https://go.telehealthfx.com/start) — TelehealthFX offers all-inclusive pricing for compounded medications. No separate "membership fees," no fighting insurance, and no local pharmacy shortages. Learn more at [https://telehealthfx.com](https://telehealthfx.com) or explore berberine options at [https://go.telehealthfx.com/berberine](https://go.telehealthfx.com/berberine).

💳 If you have seen the massive subway ads for "Ro Body," you might assume their $145/month fee includes the weight loss medication. It does not. In this episode of TelehealthFX Talk, we break down the reality of the massive telehealth platforms. We expose the "insurance concierge" illusion, the danger of playing "shortage roulette" at your local pharmacy, and why you should never pay a membership fee just to be handed a prescription you cannot fill.

👇 **HERE'S WHAT WE COVER** 👇

• 🚩 **The Disconnected "Membership Fee" Trap** — Many platforms charge a monthly membership fee (~$145) that ONLY covers the provider and the app. You still have to pay for the medication at your local pharmacy. If your insurance denies coverage (which 70% of commercial plans do), you are stuck paying $1,000+ out of pocket for the drug, on top of the membership fee.

• 🚩 **The "Insurance Concierge" Illusion** — Platforms promise to fight your insurance company for a Prior Authorization. But no concierge can force an insurance plan to cover a medication if weight loss is explicitly excluded from your employer's formulary. You wait 3 weeks just to get the inevitable denial.

• 🚩 **Playing Shortage Roulette** — Even if your insurance covers branded Wegovy or Zepbound, national shortages mean local pharmacies rarely have it in stock. You spend hours calling around town and missing doses, completely sabotaging your clinical protocol. 

⏱️ **TIMESTAMPS** ⏱️

0:00 — Introduction: The Ro Body Model

1:15 — The truth about the disconnected "Membership Fee"

2:30 — Why the "Insurance Concierge" rarely works

4:00 — Playing "Shortage Roulette" at the retail pharmacy

5:00 — How TelehealthFX flips the model (All-inclusive pricing)

6:00 — Direct-to-door shipping vs. retail pharmacies

6:45 — The TelehealthFX Difference

7:15 — Visit TelehealthFX

🔗 **TAKE THE NEXT STEP** 🔗

• Start your GLP-1 qualification quiz: [https://go.telehealthfx.com/start](https://go.telehealthfx.com/start)

• Explore berberine options: [https://go.telehealthfx.com/berberine](https://go.telehealthfx.com/berberine)

• Visit TelehealthFX: [https://telehealthfx.com](https://telehealthfx.com)

🏢 **THE TELEHEALTHFX ADVANTAGE** 🏢

TelehealthFX completely flips the model. Their pricing is ALL-INCLUSIVE for compounded medications. Stop paying for a company's massive advertising overhead. Start paying for actual clinical care and sterile, verified medication.

• ✅ The medication is INCLUDED in the price — not just a prescription.

• ✅ Bypasses insurance completely (no waiting for prior authorizations).

• ✅ Bypasses local pharmacy shortages with Direct-to-Door 2-day UPS shipping.

• ✅ Both compounded Semaglutide and Tirzepatide available.

• ✅ 24-hour provider review to answer clinical questions.

🎯 **WHO THIS EPISODE IS FOR** 🎯

Anyone currently paying a monthly membership fee to a telehealth platform but still struggling to get their medication filled. People tired of fighting with insurance companies over prior authorizations. Patients comparing online weight loss platforms like Ro, Sequence, or Found.

Subscribe to TelehealthFX Talk for honest, transparent guidance on GLP-1 weight loss. Next episode: We compare Sequence, Found, and TelehealthFX.

⚠️ **IMPORTANT DISCLAIMER** ⚠️

This content is for educational purposes only and is not medical advice. Always consult a licensed healthcare provider before starting any prescription medication. Individual results vary.

#RoBody #RoWeightLoss #Semaglutide #WeightLossTelehealth #GLP1 #OzempicAlternative #TelehealthFX #CompoundedSemaglutide #WegovyShortage #Tirzepatide #NoHiddenFees #MedicalWeightLoss

Take the free GLP-1 qualification quiz at [https://go.telehealthfx.com/start](https://go.telehealthfx.com/start) — TelehealthFX operates with no hidden fees and NO multi-month lock-in contracts. 24-hour provider review and both semaglutide and tirzepatide available. Learn more at [https://telehealthfx.com](https://telehealthfx.com) or explore berberine options at [https://go.telehealthfx.com/berberine](https://go.telehealthfx.com/berberine).

📱 If you are researching GLP-1 weight loss online, you have seen the ads for Hers. The pink branding is sleek and the introductory prices look amazing. But what happens when you actually sign up? In this episode of TelehealthFX Talk, we break down the mass-market "Big Tech" telehealth model. We expose the fine print behind the heavily advertised monthly prices, the clinical risks of their "weight loss kits," and why massive ad budgets often lead to terrible customer support when you actually need a doctor.

👇 **HERE'S WHAT WE COVER** 👇

• 🚩 **The Multi-Month Lock-In Trap** — That "$199/month" advertised price almost always requires you to prepay for 6 or 12 months upfront. If you experience severe side effects in week 2 and need to stop, or if the medication just does not work for your biology, you are financially trapped. Medical care should not be structured like an inescapable gym membership. TelehealthFX operates strictly month-to-month.

• 🚩 **The Oral "Weight Loss Kits" vs. Actual GLP-1s** — To save on costs, mass-market platforms heavily push oral weight loss pills (combinations of bupropion, naltrexone, topiramate). These are antidepressants and anti-seizure medications being used off-label. They have harsh psychological side effects (brain fog, insomnia, anxiety) and do not fix insulin resistance like a GLP-1. TelehealthFX provides direct access to real compounded semaglutide and tirzepatide.

• 🚩 **The Support Bottleneck** — When a platform brings in thousands of patients a day, getting a doctor to respond to your nausea questions can take days. TelehealthFX provides 24-hour provider review so you are never navigating side effects alone.

⏱️ **TIMESTAMPS** ⏱️

0:00 — Introduction: The Hers Weight Loss Model

1:15 — The clinical danger of multi-month lock-in contracts

3:00 — Why the oral "Weight Loss Kits" are not GLP-1s

4:45 — The psychological side effects of bupropion and topiramate

5:30 — The customer support bottleneck at massive platforms

6:30 — The TelehealthFX Difference: Month-to-month care

7:15 — Visit TelehealthFX

🔗 **TAKE THE NEXT STEP** 🔗

• Start your GLP-1 qualification quiz: [https://go.telehealthfx.com/start](https://go.telehealthfx.com/start)

• Explore berberine options: [https://go.telehealthfx.com/berberine](https://go.telehealthfx.com/berberine)

• Visit TelehealthFX: [https://telehealthfx.com](https://telehealthfx.com)

🏆 **THE TELEHEALTHFX ADVANTAGE** 🏆

• ✅ No multi-month lock-in contracts (cancel anytime)

• ✅ Transparent pricing (what you see is what you pay)

• ✅ Semaglutide AND Tirzepatide available

• ✅ 24-hour provider review

• ✅ Medications from FDA-registered compounding pharmacies

• ✅ 2-day UPS cold-chain shipping

🎯 **WHO THIS EPISODE IS FOR** 🎯

Women who are currently comparing online weight loss platforms like Hers, Ro, or Sequence. Anyone frustrated by hidden subscription fees or multi-month contracts. Patients who want real medical care, not just a branded subscription box.

Subscribe to TelehealthFX Talk for honest, transparent guidance on GLP-1 weight loss. Next episode: We break down the Ro Body alternative.

⚠️ **IMPORTANT DISCLAIMER** ⚠️

This content is for educational purposes only and is not medical advice. Always consult a licensed healthcare provider before starting any prescription medication. Individual results vary.

#HersWeightLoss #HersReview #Semaglutide #WeightLossTelehealth #GLP1 #OzempicAlternative #TelehealthFX #CompoundedSemaglutide #Wegovy #Tirzepatide #NoHiddenFees #MedicalWeightLoss

Take the free GLP-1 qualification quiz at [https://go.telehealthfx.com/start](https://go.telehealthfx.com/start) — TelehealthFX offers both semaglutide and tirzepatide, providing true metabolic oversight to lower A1C and improve insulin sensitivity. No hidden fees. Learn more at [https://telehealthfx.com](https://telehealthfx.com) or explore berberine options at [https://go.telehealthfx.com/berberine](https://go.telehealthfx.com/berberine).

🩸 They aren't just "weight loss drugs." In this episode of TelehealthFX Talk, we focus on what GLP-1 medications were originally designed to do: treat Type 2 Diabetes. We break down the head-to-head SURPASS-2 trial comparing tirzepatide and semaglutide, explain how these drugs rescue an exhausted pancreas, and discuss why the word "remission" is finally being used in diabetes care.

👇 HERE'S WHAT WE COVER 👇

• The Branding Confusion — Semaglutide = Ozempic (for diabetes) & Wegovy (for weight loss). Tirzepatide = Mounjaro (for diabetes) & Zepbound (for weight loss). The active ingredients are the exact same. They are metabolic regulators, not just cosmetic tools.

• Preserving the Pancreas (Beta-Cells) — Beta-cells produce and release insulin. In Type 2 diabetes, insulin resistance forces these cells to work overtime until they become exhausted and fail. GLP-1s change this trajectory by releasing insulin only when blood sugar is high (preventing crashes), reducing insulin resistance so the pancreas does not have to work as hard, and emerging science suggests drugs like tirzepatide may actually help reverse beta-cell damage and restore function.

• Tirzepatide vs. Semaglutide (The SURPASS-2 Trial) — A head-to-head clinical trial comparing the two drugs for Type 2 Diabetes. Result: Tirzepatide demonstrated superior A1C reduction across all doses. Tirzepatide (15 mg) produced a massive -2.3% average drop in A1C. Why choose semaglutide? It has a longer, proven track record of cardiovascular protection (preventing heart attacks/strokes), while tirzepatide's CV trials are still ongoing.

• Type 2 Diabetes Remission — Traditionally viewed as a progressive, one-way disease. But potent GLP-1s are making "remission" (A1C < 6.5% without traditional glucose meds) a realistic clinical target, drastically reducing the risk of neuropathy, blindness, and kidney failure.

⏱️ TIMESTAMPS ⏱️

0:00 — Introduction: Beyond the weight loss hype

1:00 — Clearing up the branding (Ozempic vs. Wegovy)

2:00 — The Pancreas: How beta-cells fail in Type 2 Diabetes

3:15 — How GLP-1 rescues and preserves beta-cells

4:30 — Tirzepatide vs. Semaglutide: SURPASS-2 trial data

5:30 — Why someone might choose semaglutide over tirzepatide

6:15 — The goal of Type 2 Diabetes Remission

7:00 — Why you need a metabolic health platform (TelehealthFX)

7:45 — Visit TelehealthFX

🔗 TAKE THE NEXT STEP 🔗

• Start your GLP-1 qualification quiz: [https://go.telehealthfx.com/start](https://go.telehealthfx.com/start)

• Explore berberine options: [https://go.telehealthfx.com/berberine](https://go.telehealthfx.com/berberine)

• Visit TelehealthFX: [https://telehealthfx.com](https://telehealthfx.com)

🏢 ABOUT TELEHEALTHFX 🏢

TelehealthFX is a metabolic health platform, not a pill mill. Providers offer both semaglutide and tirzepatide, tailoring your prescription based on your specific A1C goals and cardiovascular risk profile. Adjunct therapies like Berberine are available for added insulin sensitivity support. 24-hour provider review. 1-on-1 onboarding. Transparent pricing. No hidden fees. All 50 states. 2-day UPS shipping.

🎯 WHO THIS EPISODE IS FOR 🎯

Anyone with Type 2 Diabetes or Prediabetes. Patients currently taking metformin who are considering a GLP-1. Anyone confused by the difference between Ozempic, Mounjaro, Wegovy, and Zepbound. Healthcare providers looking for a clear explanation of beta-cell preservation to share with patients.

Subscribe to TelehealthFX Talk for weekly episodes on metabolic health, GLP-1 science, and clinical weight loss.

⚠️ IMPORTANT DISCLAIMER ⚠️

This content is for educational purposes only and is not medical advice. GLP-1 medications do not cure diabetes. Treatment decisions should be made in consultation with your primary care provider or endocrinologist. Individual results vary.

#Type2Diabetes #GLP1 #Tirzepatide #Semaglutide #Mounjaro #Ozempic #A1CReduction #InsulinResistance #BetaCells #SURPASS2 #DiabetesRemission #TelehealthFX #TelehealthWeightLoss #ClinicalWeightLoss #MetabolicHealth #Berberine #Prediabetes #BloodSugarControl #Endocrinology #NoHiddenFees

Take the free GLP-1 qualification quiz at [https://go.telehealthfx.com/start](https://go.telehealthfx.com/start) — TelehealthFX keeps you at the cutting edge of metabolic medicine with the current gold standards (semaglutide & tirzepatide). No hidden fees. Learn more at [https://telehealthfx.com](https://telehealthfx.com) or explore berberine options at [https://go.telehealthfx.com/berberine](https://go.telehealthfx.com/berberine).

🔬 What comes after Wegovy and Zepbound? In this episode of TelehealthFX Talk, we take you inside the 2026 clinical trials to break down the next generation of metabolic medicine. We cover the new "Triple G" agonist hitting bariatric-level weight loss, the dual-agonist rescuing fatty livers, and the new amylin pathway.

👇 HERE'S WHAT WE COVER 👇

• The Multi-Agonist Evolution — how the science moved from single targets (GLP-1) to dual targets (GLP-1 + GIP), and now to triple targets and entirely new hormone pathways.

• Survodutide (The Liver/Fat Dual Agonist) — co-agonist of GLP-1 and Glucagon (Boehringer Ingelheim). Glucagon activation increases resting calorie burn. SYNCHRONIZE-1 (Phase 3): 16.6% weight loss. Game-changer for liver health: Up to 87% of patients saw massive reductions in liver fat, offering major hope for MASH/NASH patients.

• Amycretin (The Amylin Co-Agonist) — dual agonist of GLP-1 and Amylin (Novo Nordisk). Amylin slows stomach emptying through a completely different neural pathway. Developed as BOTH an injection and a daily pill. Phase 2 data showed the oral pill producing over 10% weight loss in just 36 weeks without plateauing.

• Retatrutide (The "Triple G" Agonist) — triple hormone agonist: GLP-1 + GIP + Glucagon (Eli Lilly). TRIUMPH-4 Phase 3 trial (Dec 2025): 28.7% average weight loss (approx 71 lbs) at 68 weeks on the highest dose. Produces results that rival gastric bypass surgery. Potential FDA filing late 2026/early 2027.

• Orforglipron (Foundayo) — newly FDA-approved (April 2026) non-peptide oral pill. No fasting required.

⏱️ TIMESTAMPS ⏱️

0:00 — Introduction: Beyond semaglutide and tirzepatide

1:00 — The evolution of multi-agonist drugs

1:45 — Survodutide: GLP-1 + Glucagon and liver fat

3:15 — Amycretin: The new Amylin pathway (pill & injection)

4:30 — Orforglipron (Foundayo): The no-fasting pill

5:00 — Retatrutide: The "Triple G" agonist (28.7% weight loss)

6:30 — Why you need a comprehensive clinical platform

7:15 — Start today with the current gold standards

7:45 — Visit TelehealthFX

🔗 TAKE THE NEXT STEP 🔗

• Start your GLP-1 qualification quiz: [https://go.telehealthfx.com/start](https://go.telehealthfx.com/start)

• Explore berberine options: [https://go.telehealthfx.com/berberine](https://go.telehealthfx.com/berberine)

• Visit TelehealthFX: [https://telehealthfx.com](https://telehealthfx.com)

🏢 ABOUT TELEHEALTHFX 🏢

TelehealthFX offers the current clinical gold standards: injectable semaglutide and tirzepatide, plus metabolic support like NAD+ and sermorelin. By choosing a true clinical platform, you ensure your care evolves with the science, rather than getting stuck at a single-drug clinic. 24-hour provider review. 1-on-1 onboarding. Transparent pricing. No hidden fees. All 50 states. 2-day UPS shipping.

🎯 WHO THIS EPISODE IS FOR 🎯

Anyone interested in the future of obesity medicine and metabolic science. Patients with fatty liver disease (MASH/NASH) looking for future treatments. People who want to understand the difference between GLP-1, GIP, Glucagon, and Amylin. Current GLP-1 users curious about what the next 2-3 years will bring.

Subscribe to TelehealthFX Talk for weekly episodes on GLP-1 science, clinical weight loss, and the future of metabolic health.

⚠️ IMPORTANT DISCLAIMER ⚠️

This content is for educational purposes only and is not medical advice. With the exception of orforglipron, the next-gen drugs discussed (retatrutide, survodutide, amycretin) are investigational, currently in clinical trials, and not yet FDA approved for public use. Always consult your healthcare provider regarding weight loss treatments. Individual results vary.

#Retatrutide #Survodutide #Amycretin #GLP1Pipeline #NextGenWeightLoss #TripleAgonist #Orforglipron #Foundayo #MASH #FattyLiver #Amylin #Glucagon #Semaglutide #Tirzepatide #TelehealthFX #TelehealthWeightLoss #ClinicalWeightLoss #ObesityMedicine #WeightLossScience #NoHiddenFees

Take the free GLP-1 qualification quiz at [https://go.telehealthfx.com/start](https://go.telehealthfx.com/start) — TelehealthFX provides clinical oversight for women, including family planning and contraceptive guidance. No hidden fees. Learn more at [https://telehealthfx.com](https://telehealthfx.com) or explore berberine options at [https://go.telehealthfx.com/berberine](https://go.telehealthfx.com/berberine).

👶 Are "Ozempic Babies" real? Yes. In this episode of TelehealthFX Talk, we break down the biology behind the massive viral trend of surprise pregnancies on GLP-1 medications. We explain how semaglutide and tirzepatide restore fertility, why they can cause oral birth control pills to fail, and the strict safety guidelines every woman of reproductive age needs to follow.

👇 HERE'S WHAT WE COVER 👇

• The "Ozempic Baby" Phenomenon — two biological causes:

  - Restored Fertility: GLP-1s are NOT fertility drugs, but they improve insulin sensitivity and lower inflammation. For women with PCOS or obesity-related anovulation, this weight loss "wakes up" the reproductive system. Women who assumed they were infertile suddenly start ovulating normally again.

  - Birth Control Interference: GLP-1 medications slow gastric emptying (stomach digestion). This delayed emptying can prevent oral contraceptive pills from being fully absorbed. Plus, GI side effects (vomiting) can expel the pill. Result: the pill fails.

• Clinical Guidance on Birth Control:

  - Women on GLP-1s should not rely solely on oral birth control pills.

  - Experts recommend switching to non-oral methods (IUDs, implants, injections) or using backup barrier methods (condoms).

• Pregnancy Safety & Guidelines (2026):

  - Is it safe during pregnancy? NO. Animal studies show potential fetal risks.

  - If you discover you are pregnant: Stop the medication immediately and call your OB-GYN.

  - The 8-Week Washout: If you are trying to conceive (TTC), FDA guidelines mandate stopping GLP-1 medications at least 2 months (8 weeks) before attempting to get pregnant.

• The Catch-22 of Stopping Medication:

  - Many women use GLP-1 to get healthy enough to conceive.

  - Stopping the medication 2 months before pregnancy can cause rebound weight gain and a return of insulin resistance.

  - Requires tight clinical coordination between your endocrinologist and OB-GYN to protect your metabolic health during the gap.

⏱️ TIMESTAMPS ⏱️

0:00 — Introduction: The viral "Ozempic Baby" trend

1:00 — Mechanism 1: Restored fertility & PCOS

2:15 — Mechanism 2: Birth control pill interference

3:30 — Clinical advice on contraception

4:00 — Pregnancy safety: Why it is not recommended

4:45 — The mandatory 8-week "washout period"

5:30 — The Catch-22: Stopping the medication before pregnancy

6:30 — Why you need a clinical team, not just a prescription

7:15 — TelehealthFX: Comprehensive women's health

7:45 — Visit TelehealthFX

🔗 TAKE THE NEXT STEP 🔗

• Start your GLP-1 qualification quiz: [https://go.telehealthfx.com/start](https://go.telehealthfx.com/start)

• Explore berberine options: [https://go.telehealthfx.com/berberine](https://go.telehealthfx.com/berberine)

• Visit TelehealthFX: [https://telehealthfx.com](https://telehealthfx.com)

🏢 ABOUT TELEHEALTHFX 🏢

TelehealthFX offers a comprehensive clinical program. 1-on-1 onboarding includes discussions on family planning and birth control interactions. Access to semaglutide, tirzepatide, and metabolic supplements like berberine (highly effective for PCOS support). 24-hour provider review. Transparent pricing. No hidden fees. All 50 states. 2-day UPS shipping.

🎯 WHO THIS EPISODE IS FOR 🎯

Any woman of reproductive age currently taking or considering a GLP-1 medication. Women with PCOS or a history of infertility. Women relying on oral birth control pills while on semaglutide or tirzepatide. Women planning to try to conceive in the next year.

Subscribe to TelehealthFX Talk for weekly episodes on GLP-1 science, women's health, and clinical weight loss.

⚠️ IMPORTANT DISCLAIMER ⚠️

This content is for educational purposes only and is not medical advice. GLP-1 medications are not approved for use during pregnancy. Always consult your prescribing physician and OB-GYN regarding contraception, fertility, and pregnancy. Individual results vary.

#OzempicBabies #GLP1Fertility #PCOSWeightLoss #SemaglutidePregnancy #BirthControl #Tirzepatide #OzempicPregnancy #Wegovy #Mounjaro #Zepbound #TelehealthFX #TelehealthWeightLoss #ClinicalWeightLoss #WomensHealth #PCOS #InsulinResistance #FertilityJourney #TryingToConceive #WeightLoss #NoHiddenFees #Berberine

Take the free GLP-1 qualification quiz at [https://go.telehealthfx.com/start](https://go.telehealthfx.com/start) — TelehealthFX offers injectable semaglutide and tirzepatide, the clinical gold standards, with providers who help you choose the right format for your life. No hidden fees. Learn more at [https://telehealthfx.com](https://telehealthfx.com) or explore berberine options at [https://go.telehealthfx.com/berberine](https://go.telehealthfx.com/berberine).

💊 Hate needles? The oral GLP-1 revolution is here. In this episode of TelehealthFX Talk, we compare every oral and injectable GLP-1 option available in 2026, break down the brand-new orforglipron (Foundayo) approval, and explain what's still coming in the pipeline — including oral tirzepatide.

👇 HERE'S WHAT WE COVER 👇

• The oral GLP-1 timeline:

  - Rybelsus (oral semaglutide 3/7/14 mg): FDA-approved for Type 2 diabetes

  - Dec 2025: Oral Wegovy (25 mg daily) approved for weight management

  - April 1, 2026: Orforglipron (Foundayo) — first non-peptide oral GLP-1 — approved for weight management

  - In development: oral tirzepatide (Eli Lilly, late-stage)

• The bioavailability problem — oral semaglutide is a peptide destroyed by stomach acid (~0.4-1% absorption). Requires strict fasting: empty stomach, AM only, ≤4 oz water, wait 30 min. Orforglipron is a NON-PEPTIDE small molecule — NOT destroyed by stomach acid. Take anytime, with or without food, no restrictions.

• Orforglipron (Foundayo) — the game-changer:

  - First-in-class non-peptide oral GLP-1 receptor agonist

  - FDA approved April 1, 2026 for chronic weight management

  - ACHIEVE-3 (Lancet Feb 2026): outperformed oral semaglutide in A1C AND weight loss

  - ATTAIN-1/ATTAIN-2: significant sustained weight loss over 72 weeks

  - ATTAIN-MAINTAIN: successful maintenance switching from injectable to oral

  - Take like any other pill — no fasting, no timing gymnastics

• Oral vs. injectable comparison:

  - Injectable (Wegovy/Ozempic): Weekly frequency | No fasting | ~100% bioavailability | Gold standard weight loss (12-15%+)

  - Oral Semaglutide: Daily frequency | Strict fasting | 0.4-1% bioavailability | Competitive weight loss

  - Orforglipron: Daily frequency | No fasting | Higher bioavailability (non-peptide) | Competitive weight loss

• Who should choose oral vs. injectable:

  - Oral: needle-phobic, travelers, daily routine preference

  - Injectable: once-weekly convenience, maximum potency, already stable

• Pipeline: oral tirzepatide (dual-agonist pill), triple agonists (GLP-1+GIP+glucagon)

⏱️ TIMESTAMPS ⏱️

0:00 — Introduction: the needle barrier is disappearing

1:00 — Oral GLP-1 timeline: Rybelsus to Foundayo

1:45 — The bioavailability problem explained

2:30 — Why oral semaglutide requires strict fasting

3:00 — Orforglipron: non-peptide game-changer

3:45 — Clinical trial data: ACHIEVE-3, ATTAIN

4:30 — Oral vs. injectable: side-by-side comparison

5:15 — Who should choose which format

6:00 — Pipeline: oral tirzepatide and triple agonists

6:45 — TelehealthFX: the right format for your life

7:45 — Visit TelehealthFX

🔗 TAKE THE NEXT STEP 🔗

• Start your GLP-1 qualification quiz: [https://go.telehealthfx.com/start](https://go.telehealthfx.com/start)

• Explore berberine options: [https://go.telehealthfx.com/berberine](https://go.telehealthfx.com/berberine)

• Visit TelehealthFX: [https://telehealthfx.com](https://telehealthfx.com)

🏢 ABOUT TELEHEALTHFX 🏢

Injectable semaglutide and tirzepatide — current clinical gold standards. Providers evaluate your preferences and lifestyle. NAD+, sermorelin, berberine. 24-hour provider review. 1-on-1 onboarding. Transparent pricing. No hidden fees. All 50 states. 2-day UPS shipping.

🎯 WHO THIS EPISODE IS FOR 🎯

Anyone who has avoided GLP-1 because of needle phobia. Anyone curious about the new oral options approved in 2025-2026. Anyone currently on injectable who wonders if oral could work. Anyone interested in the future pipeline of GLP-1 medications.

Subscribe to TelehealthFX Talk Season 2 for new episodes on GLP-1 innovation, oral medications, and clinical wellness.

⚠️ IMPORTANT DISCLAIMER ⚠️

This content is for educational purposes only and is not medical advice. Do not switch between oral and injectable formulations without consulting your healthcare provider. Drug availability and pipeline timelines are subject to change. Individual results vary.

#OralGLP1 #Orforglipron #Foundayo #OralSemaglutide #Rybelsus #OralWegovy #GLP1Pill #NoNeedles #GLP1 #Semaglutide #Tirzepatide #TelehealthFX #TelehealthWeightLoss #ClinicalWeightLoss #WeightLossPill #GLP1Pipeline #ObesityMedicine #NoHiddenFees #WeightLoss #OralWeightLoss #NeedleFree #GLP1Innovation #FutureOfWeightLoss #SmallMolecule

Take the free GLP-1 qualification quiz at [https://go.telehealthfx.com/start](https://go.telehealthfx.com/start) — TelehealthFX offers semaglutide, the ONLY obesity medication with proven cardiovascular protection. Licensed clinicians evaluate your cardiovascular risk as part of the assessment. No hidden fees. Learn more at [https://telehealthfx.com](https://telehealthfx.com) or explore berberine options at [https://go.telehealthfx.com/berberine](https://go.telehealthfx.com/berberine).

❤️ SEASON 2 PREMIERE! Semaglutide does not just help you lose weight. It reduces heart attacks, strokes, and cardiovascular death by 20%. In this episode of TelehealthFX Talk, we break down the landmark SELECT trial, the STEP-HFpEF heart failure data, and the 8 mechanisms through which GLP-1 directly protects your heart — beyond weight loss.

👇 HERE'S WHAT WE COVER 👇

• The SELECT Trial — the data that changed everything:

  - 17,604 adults with overweight/obesity AND established cardiovascular disease (no diabetes)

  - Semaglutide 2.4 mg weekly vs. placebo, 3.3 years follow-up

  - Primary endpoint: MACE (cardiovascular death + nonfatal heart attack + nonfatal stroke)

  - Result: 20% reduction in MACE (HR 0.80, p<0.001)

  - Benefits were INDEPENDENT of amount of weight lost

  - First obesity medication EVER to receive FDA cardiovascular indication

  - Published in the New England Journal of Medicine

• STEP-HFpEF — heart failure breakthrough:

  - Semaglutide in obesity-related heart failure with preserved ejection fraction

  - Significantly improved heart failure symptoms and quality of life

  - Improved exercise capacity (6-minute walk test)

  - Reduced inflammation markers (hsCRP)

  - Attenuated adverse cardiac remodeling

  - Benefits consistent across all ages including 75+

  - Improvements beyond what weight loss alone explains

• 8 mechanisms of cardiovascular protection:

  - Anti-inflammatory effects — reduces CRP, slows atherosclerosis

  - Slows plaque buildup in arteries

  - Modest, consistent blood pressure lowering

  - Improved cholesterol/lipid markers

  - Dramatic visceral fat reduction

  - Improved endothelial function (healthier blood vessel lining)

  - Favorable cardiac remodeling — reduced heart strain

  - Direct GLP-1 receptor effects on cardiac tissue

• What this means for you:

  - GLP-1 is NOT a "vanity drug" — it is a cardiovascular intervention

  - Puts semaglutide in the same category as statins for heart protection

  - For people with obesity + heart risk: potentially lifesaving

  - Strengthens insurance coverage/medical necessity arguments

  - Reframes the entire GLP-1 conversation

⏱️ TIMESTAMPS ⏱️

0:00 — Season 2 premiere: the data that changes everything

1:00 — Heart disease is #1 cause of death

1:30 — SELECT trial: 17,604 patients, 3.3 years

2:30 — The result: 20% MACE reduction

3:15 — Benefits independent of weight loss

3:45 — 8 mechanisms of heart protection

5:00 — STEP-HFpEF: heart failure breakthrough

5:45 — First obesity drug with FDA cardiovascular indication

6:15 — What this means: not vanity, it is longevity

7:00 — TelehealthFX: proven cardiovascular protection

7:45 — Visit TelehealthFX

🔗 TAKE THE NEXT STEP 🔗

• Start your GLP-1 qualification quiz: [https://go.telehealthfx.com/start](https://go.telehealthfx.com/start)

• Explore berberine options: [https://go.telehealthfx.com/berberine](https://go.telehealthfx.com/berberine)

• Visit TelehealthFX: [https://telehealthfx.com](https://telehealthfx.com)

🏢 ABOUT TELEHEALTHFX 🏢

The only obesity medication with proven cardiovascular protection. Licensed clinicians evaluate cardiovascular risk. Semaglutide, tirzepatide, sermorelin, NAD+, berberine. 24-hour provider review. 1-on-1 onboarding. Transparent pricing. No hidden fees. All 50 states. 2-day UPS shipping.

🎯 WHO THIS EPISODE IS FOR 🎯

Anyone with obesity and cardiovascular risk factors (high BP, cholesterol, family history). Anyone who thinks GLP-1 is "just" a weight loss drug. Anyone with a family member who has heart disease and is overweight. Healthcare providers who want the SELECT trial explained clearly. Anyone evaluating whether GLP-1 medication is medically appropriate for them.

Subscribe to TelehealthFX Talk Season 2 for new episodes on GLP-1 science, cardiovascular health, and clinical wellness.

⚠️ IMPORTANT DISCLAIMER ⚠️

This content is for educational purposes only and is not medical advice. Cardiovascular disease management should involve your cardiologist and primary care provider. Not all GLP-1 medications have the same cardiovascular data; tirzepatide's CV outcomes trial is ongoing. Individual results vary.

#SELECTTrial #GLP1Heart #SemaglutideHeart #CardiovascularProtection #HeartHealth #HeartAttackPrevention #GLP1 #Semaglutide #Tirzepatide #TelehealthFX #TelehealthWeightLoss #ClinicalWeightLoss #MACE #HeartFailure #HFpEF #ObesityMedicine #WeightLoss #NoHiddenFees #CardiacHealth #StrokePrevention #OzempicHeart #CardiovascularRisk #HeartDisease #LongevityMedicine

Take the free GLP-1 qualification quiz at [https://go.telehealthfx.com/start](https://go.telehealthfx.com/start) — TelehealthFX's comprehensive approach (GLP-1 + sermorelin + NAD+ + protein guidance) inherently gives your skin the best chance to adapt during weight loss. No hidden fees. Learn more at [https://telehealthfx.com](https://telehealthfx.com) or explore berberine options at [https://go.telehealthfx.com/berberine](https://go.telehealthfx.com/berberine).

🎉 SEASON FINALE! Will GLP-1 make your face look old? Will your skin sag? In this final episode of TelehealthFX Talk Season 1, we separate the myths from the science on "Ozempic face" and loose skin, give you a specific 7-strategy prevention framework, and walk through every treatment option available — from non-surgical to surgical.

👇 HERE'S WHAT WE COVER 👇

• What is "Ozempic face"? — NOT a drug-specific side effect. It is a consequence of rapid, significant weight loss regardless of method. Facial fat pads shrink → hollowed, deflated appearance. Skin cannot retract fast enough → sagging. Muscle loss compounds the effect. Age-related collagen decline makes it worse. Vanderbilt 2025 study documented measurable midfacial volume decrease.

• Loose skin (the body version):

  - Skin stretched by prolonged weight gain; collagen/elastin fibers damaged

  - When fat volume decreases, skin may not retract fully

  - 5 factors determining severity: speed of weight loss, total amount lost, age, genetics, lifestyle (smoking, sun, hydration, protein)

• THE 7-STRATEGY PREVENTION FRAMEWORK:

  - 1. Moderate weight loss pace: ~1-2 lbs/week gives skin time to adapt. GLP-1 already produces more gradual loss than surgery.

  - 2. Maximize protein: 0.7-1.0 g/lb body weight/day. Essential for collagen repair + muscle preservation. Collagen peptide supplements as additional support.

  - 3. Resistance training: builds muscle beneath skin = structural support that fills volume where fat was lost.

  - 4. Hydration: minimum 64 oz/day. Dehydrated skin loses elasticity faster.

  - 5. Nutritional support: vitamin C (collagen synthesis), omega-3s (skin barrier), zinc (skin repair), antioxidants (protect collagen).

  - 6. Sun protection: SPF 30+ daily. Single most impactful anti-aging skin intervention. UV breaks down collagen and elastin.

  - 7. Avoid smoking: directly accelerates collagen/elastin degradation.

• TREATMENT OPTIONS (post-weight loss):

  - Non-surgical (mild to moderate): Dermal fillers to restore facial volume, biostimulatory treatments (Sculptra) to stimulate the body's own collagen, radiofrequency (RF) skin tightening, microneedling with RF, and ultrasound-based tightening.

  - Surgical (moderate to severe): Abdominoplasty (tummy tuck), body lifts (circumferential), arm lifts (brachioplasty), thigh lifts, and face/neck lifts. Timing: wait until weight is stable (within 5-10 lbs) for 3-6 months.

• How TelehealthFX's comprehensive approach inherently addresses skin:

  - GLP-1 for gradual weight loss (better for skin adaptation)

  - Sermorelin for lean mass (fills volume where fat was lost)

  - NAD+ for cellular repair infrastructure

  - Protein guidance during 1-on-1 onboarding

  - Complete approach addresses ALL factors contributing to skin laxity

• SEASON 1 RECAP — 20 EPISODES:

  - EP01: FDA Compounding Ban | EP02: Muscle Loss | EP03: Real Cost of GLP-1 | EP04: GLP-1 Side Effects | EP05: How GLP-1 Works | EP06: Berberine | EP07: Weight Regain | EP08: Exercise on GLP-1 | EP09: Women Over 40 | EP10: Berberine for PCOS | EP11: Tirzepatide vs. Semaglutide | EP12: GLP-1 & Alcohol | EP13: Men's Weight Loss | EP14: NAD+ Therapy | EP15: Compounded Safety | EP16: Mental Health | EP17: Sermorelin | EP18: Seniors Over 60 | EP19: Plateau | EP20: Ozempic Face & Loose Skin

⏱️ TIMESTAMPS ⏱️

0:00 — Season finale: the topic you have been waiting for

1:00 — "Ozempic face" is NOT a drug side effect

1:45 — Facial fat pads and volume loss explained

2:30 — Loose skin: the 5 factors

3:15 — Prevention strategy #1-2: pace and protein

4:00 — Prevention strategies #3-4: resistance training and hydration

4:30 — Prevention strategies #5-7: nutrition, sun, smoking

5:15 — Non-surgical treatment options

6:00 — Surgical treatment options and timing

6:30 — How TelehealthFX's approach addresses skin

7:15 — Season 1 recap: 20 episodes of clinical education

7:45 — Visit TelehealthFX

🔗 TAKE THE NEXT STEP 🔗

• Start your GLP-1 qualification quiz: [https://go.telehealthfx.com/start](https://go.telehealthfx.com/start)

• Explore berberine options: [https://go.telehealthfx.com/berberine](https://go.telehealthfx.com/berberine)

• Visit TelehealthFX: [https://telehealthfx.com](https://telehealthfx.com)

🏢 ABOUT TELEHEALTHFX 🏢

Semaglutide, tirzepatide, sermorelin, NAD+, berberine — all under licensed clinician guidance. 24-hour provider review. 1-on-1 onboarding. Transparent pricing. No hidden fees. All 50 states. 2-day UPS shipping.

🎯 WHO THIS EPISODE IS FOR 🎯

Anyone worried about "Ozempic face" or loose skin from GLP-1 weight loss. Anyone currently experiencing facial volume loss or skin laxity during weight loss. Anyone wanting a prevention plan before starting GLP-1 medications. Anyone curious about treatment options for loose skin after significant weight loss.

Thank you for listening to Season 1 of TelehealthFX Talk! Subscribe for Season 2 — new episodes coming soon.

⚠️ IMPORTANT DISCLAIMER ⚠️

This content is for educational purposes only and is not medical advice. Cosmetic concerns should be discussed with a board-certified dermatologist or plastic surgeon. Individual results vary.

#OzempicFace #LooseSkin #GLP1WeightLoss #SkinAfterWeightLoss #CollagenSupport #WeightLossSkin #GLP1 #Semaglutide #Tirzepatide #TelehealthFX #TelehealthWeightLoss #ClinicalWeightLoss #BodyContouring #SkinTightening #DermalFillers #MusclePreservation #WeightLoss #Sermorelin #NADTherapy #NoHiddenFees #OzempicAlternative #WeightLossProgram #HealthySkin #AntiAging #SeasonFinale

Take the free GLP-1 qualification quiz at [https://go.telehealthfx.com/start](https://go.telehealthfx.com/start) — TelehealthFX providers help you navigate plateaus, adjust dosing, and switch medications when needed. No hidden fees. Learn more at [https://telehealthfx.com](https://telehealthfx.com) or explore berberine options at [https://go.telehealthfx.com/berberine](https://go.telehealthfx.com/berberine).

🛑 Your GLP-1 weight loss stalled? DON'T QUIT. In this episode of TelehealthFX Talk, we explain exactly why weight loss plateaus happen on semaglutide and tirzepatide, break down the 4 biological mechanisms causing the stall, and give you a specific 7-strategy framework to break through it.

👇 HERE'S WHAT WE COVER 👇

• Plateaus are NORMAL — after initial rapid loss, weight stabilizes around 9-18 months of treatment. Nearly every GLP-1 patient experiences some form of plateau. NOT a sign the medication stopped working.

• 4 biological mechanisms causing plateaus:

  - Metabolic adaptation (adaptive thermogenesis) — a smaller body burns fewer calories. The deficit that worked at 250 lbs does not work at 200 lbs.

  - Set point theory — the body defends a "preferred" weight range. Ghrelin (hunger) increases, leptin (fullness) decreases, creating biological resistance.

  - Muscle loss → metabolic slowdown — less muscle = lower resting metabolic rate = harder to continue losing fat.

  - Behavioral drift — subtle, unconscious loosening of diet/exercise habits. Often reveals 200-500 hidden daily calories.

• THE 7-STRATEGY PLATEAU-BREAKER FRAMEWORK:

  - Strategy 1: Audit your protein — target 0.7-1.0 g/lb body weight/day, 25-40g per meal. Preserves muscle, increases thermic effect, boosts satiety.

  - Strategy 2: Prioritize resistance training — THE most important intervention. Builds metabolically active muscle. Minimum 2-3x/week with progressive overload.

  - Strategy 3: Track everything for 2 weeks — measure portions (do not estimate), include drinks, snacks, sauces, cooking oils. Hidden calorie creep is the #1 fixable cause.

  - Strategy 4: Optimize sleep — poor sleep increases ghrelin, decreases leptin, increases cortisol. Target 7-9 hours/night.

  - Strategy 5: Manage stress — chronic stress elevates cortisol → visceral fat storage + emotional eating. Walking, meditation, boundaries, recovery days.

  - Strategy 6: Review dose with provider — may not be at max therapeutic dose. Consider medication switch (e.g., semaglutide → tirzepatide: SURMOUNT-5 showed 20.2% vs 13.7% weight loss).

  - Strategy 7: Redefine success — scale is not everything. Measure waist, clothes fit, energy, mobility, lab work. Maintenance at a lower weight IS success.

⏱️ TIMESTAMPS ⏱️

0:00 — Introduction: Don't quit

1:00 — Plateaus are NORMAL (9-18 months)

1:30 — Mechanism #1: metabolic adaptation

2:15 — Mechanism #2: set point theory

2:45 — Mechanism #3: muscle loss

3:15 — Mechanism #4: behavioral drift

3:45 — Strategy #1: audit your protein

4:15 — Strategy #2: resistance training

4:45 — Strategy #3: track everything for 2 weeks

5:15 — Strategies #4-5: sleep and stress

5:45 — Strategy #6: dose review and medication switch

6:30 — Strategy #7: redefine success

7:00 — TelehealthFX: plateau navigation

7:45 — Visit TelehealthFX

🔗 TAKE THE NEXT STEP 🔗

• Start your GLP-1 qualification quiz: [https://go.telehealthfx.com/start](https://go.telehealthfx.com/start)

• Explore berberine options: [https://go.telehealthfx.com/berberine](https://go.telehealthfx.com/berberine)

• Visit TelehealthFX: [https://telehealthfx.com](https://telehealthfx.com)

🏢 ABOUT TELEHEALTHFX 🏢

Providers who help navigate plateaus, not just prescribe and disappear. Evaluate dose adjustments, medication switches (both semaglutide AND tirzepatide on one platform), adding sermorelin or NAD+. 24-hour provider review. 1-on-1 support. Transparent pricing. No hidden fees. All 50 states. 2-day UPS shipping.

🎯 WHO THIS EPISODE IS FOR 🎯

Anyone on semaglutide or tirzepatide whose weight loss has slowed or stopped. Anyone feeling frustrated or considering quitting their GLP-1 medication. Anyone who wants a specific, actionable plan to restart progress. Anyone who wants to understand the biology behind why plateaus happen.

Subscribe to TelehealthFX Talk for weekly episodes on GLP-1 weight loss, plateau management, and clinical wellness.

⚠️ IMPORTANT DISCLAIMER ⚠️

This content is for educational purposes only and is not medical advice. Do not adjust medication dosage or switch medications without consulting your healthcare provider. Individual results vary.

#WeightLossPlateau #GLP1Plateau #OzempicPlateau #SemaglutidePlateau #WeightLossStall #GLP1 #Semaglutide #Tirzepatide #BreakThroughPlateau #MetabolicAdaptation #TelehealthFX #TelehealthWeightLoss #ClinicalWeightLoss #WeightLoss #ProteinIntake #ResistanceTraining #NoHiddenFees #NADTherapy #Sermorelin #WeightLossJourney #DontQuit #PlateauBreaker #WeightLossProgram #SetPointTheory

Take the free GLP-1 qualification quiz at [https://go.telehealthfx.com/start](https://go.telehealthfx.com/start) — TelehealthFX evaluates the full picture including existing medications, kidney function, bone health, and fall risk. No hidden fees. Delivered to your door. Learn more at [https://telehealthfx.com](https://telehealthfx.com) or explore berberine options at [https://go.telehealthfx.com/berberine](https://go.telehealthfx.com/berberine).

🩺 Can seniors safely use GLP-1 medications for weight loss? In this episode of TelehealthFX Talk, we break down the unique health risks of obesity after 60, explain the weight loss paradox that makes clinicians cautious, cover the special safety considerations for older adults on semaglutide or tirzepatide, and give you a complete safe weight loss framework designed for seniors.

👇 HERE'S WHAT WE COVER 👇

• Obesity after 60 (the stakes) — ~30-40% of US adults over 60 are obese. Fall risk is 25-31% higher in obese older adults, leading to reduced mobility and difficulty with daily activities. This accelerates osteoarthritis, cardiovascular disease, type 2 diabetes, and sleep apnea. The biggest hidden danger is sarcopenic obesity: excess fat plus low muscle mass.

• The weight loss paradox for seniors — when you lose weight, you do not just lose fat. You also lose muscle and bone. For seniors already experiencing age-related decline, this can increase fracture risk and impair function. Rapid weight loss is especially dangerous. The goal is to lose FAT while preserving muscle and bone.

• How GLP-1 helps seniors specifically — provides moderate appetite suppression (500-700 kcal/day deficit, NOT aggressive), improves insulin sensitivity, and offers cardiovascular risk reduction (based on semaglutide data). Even 5-10% weight loss significantly improves mobility, joint pain, and sleep apnea.

• Special safety considerations for seniors:

  - Start low, go slow — more gradual dose titration

  - Dehydration risk — GI side effects are more dangerous for older adults

  - Muscle preservation — pair with protein (1.0-1.2 g/kg/day) and resistance training 2x/week

  - Bone monitoring — periodic DEXA scans, calcium 1,000-1,200 mg, vitamin D 800-1,000 IU

  - Polypharmacy — thorough medication interaction review

  - Kidney function — may need dose adjustments

  - Fall risk — regular balance and gait assessment

  - NOT appropriate for frail or underweight seniors

• Safe weight loss framework — includes moderate caloric restriction, high protein at every meal (25-30g per meal), resistance training a minimum of 2x/week, balance training for fall prevention, and bone health supplementation. Body composition monitoring ensures you are losing fat, not muscle. The focus is prioritizing function and independence over scale weight.

• Why telehealth works for seniors — no driving to the clinic, no waiting rooms, and consultations with a provider from home. Adult children can help navigate the process, and everything is delivered directly to your door.

⏱️ TIMESTAMPS ⏱️

0:00 — Introduction: Why seniors are overlooked

1:00 — Obesity after 60: falls, mobility, independence

2:00 — Sarcopenic obesity: the hidden danger

2:45 — The weight loss paradox: muscle and bone risk

3:30 — How GLP-1 helps seniors specifically

4:15 — Safety consideration #1-3: titration, dehydration, protein

5:15 — Safety considerations #4-7: bone, medications, kidneys, falls

6:00 — Complete safe weight loss framework

6:45 — Why telehealth works for seniors

7:15 — Independence vs. dependence

7:45 — Visit TelehealthFX

🔗 TAKE THE NEXT STEP 🔗

• Start your GLP-1 qualification quiz: [https://go.telehealthfx.com/start](https://go.telehealthfx.com/start)

• Explore berberine options: [https://go.telehealthfx.com/berberine](https://go.telehealthfx.com/berberine)

• Visit TelehealthFX: [https://telehealthfx.com](https://telehealthfx.com)

🏢 ABOUT TELEHEALTHFX 🏢

Providers evaluate the full picture: medications, kidney function, bone health, and fall risk. 1-on-1 onboarding is provided for senior-specific concerns. TelehealthFX offers GLP-1, sermorelin, NAD+, and berberine. Transparent pricing. No hidden fees. Available in all 50 states with 2-day UPS shipping.

🎯 WHO THIS EPISODE IS FOR 🎯

Adults over 60 struggling with weight that affects mobility, independence, or health. Adult children concerned about an aging parent's weight and health. Seniors who have been told to "just lose weight" without receiving guidance on how to do so safely. Healthcare providers looking for a framework for safe weight management in older patients.

Subscribe to TelehealthFX Talk for weekly episodes on GLP-1 weight loss, senior health, and clinical wellness.

⚠️ IMPORTANT DISCLAIMER ⚠️

This content is for educational purposes only and is not medical advice. Weight loss in older adults carries specific risks and should only be undertaken with qualified clinical supervision, ideally from a provider experienced in geriatric care. Individual results vary.

#WeightLossOver60 #SeniorWeightLoss #GLP1ForSeniors #SarcopenicObesity #FallPrevention #ElderlyHealth #GLP1 #Semaglutide #Tirzepatide #TelehealthFX #TelehealthWeightLoss #ClinicalWeightLoss #BoneDensity #MusclePreservation #OzempicAlternative #NoHiddenFees #SeniorFitness #HealthyAging #WeightManagement #NADTherapy #Sermorelin #GeriatricHealth #IndependentLiving #WeightLossProgram